Threonine 161 phosphorylation of p34cdc2 and its equivalent threonine 160 in p33cdk2 by cdk-activating kinase (CAK) is essential for the activation of these cyclin-dependent kinases. We have studied the expression and associated kinase activity of p40MOl5, the catalytic subunit of CAK, during Xenopus oogenesis, meiotic maturation, and early development to understand in more detail how cdk kinases are regulated during these events. We find that p40M°15 is a stable protein with a half-life >16 h that is accumulated during oogenesis. p4OMOl5 protein and its associated CAK activity are localized predominantly to the germinal vesicle; however, a small but significant proportion is found in the cytoplasm. The amount of p4oMO15 detected in stage VI oocytes remains unchanged through meiotic maturation, fertilization, and early embryogenesis. Significantly, p4OMO15 was found to be constitutively active during oogenesis, meiotic maturation, and the rapid mitotic cycles of early development. This suggests that regulation of p34cdc2 and p33cdk2 activity during cell cycle progression does not involve changes in the level or activity of p4OMOl5/CAK.
INTRODUCTION
Current understanding of cell cycle control emphasizes the key role played by complexes formed between cyclin-dependent kinases (cdk's) and cyclins (Norbury and Nurse, 1992) . The first cdk to be identified was p34cdc2, the product of the CDC2 gene in fission yeast, and its homologue CDC28 in budding yeast. In a complex formed with G2/M-phase specific (B-type) cycins, homologues of p34cdc2 are responsible for controlling entry into meiotic and mitotic M-phases in all eukaryotic cells (Moreno et al., 1989; Nurse, 1990) . In yeast, p34cdc2 complexed with Gl-or S-phase specific cyclins is also required for passage through the start control point in Gl and S phase and may be the only cdk required to drive the cell cycle in these cells (Lew and Reed, 1992; Nasmyth, 1993) . In higher eukaryotes the picture is more complex with a family of at least six known cdk's, each of which functions at different points in the cell cycle, partnered by one of the cycin A, B, D, or E family of proteins (reviewed by Pines, 1993; Sherr, 1993) . The precise function of each cdk-cyclin complex has yet to be established, but the increasing amount of information for p34Cdc2 (=p34cdkl) and the closely related kinase p33Cdk2 (Elledge and Spottswood, 1991; Paris et al., 1991) has revealed many aspects of their regulation during cell cycle progression.
The activity, localization, and probably substrate specificity of p34cdc2 and p33C"2 are regulated at several levels. First, the periodic expression of essential cyclin subunits during the cell cycle ensures that cdk activation only occurs at the appropriate time and place (Reed, 1992; Sherr, 1993) . Second, the catalytic activity of the complex is subsequently controlled by cyclin-dependent phosphorylation and dephosphorylation of specific tyrosine and threonine residues (Norbury et al., 1991; Solomon et al., 1992; Draetta, 1993) . Third, small inhibitory proteins have recently been discovered that form stable ternary complexes with cdk-cyclin, inhibiting protein kinase activity and negatively regulating progression through Gl (reviewed by Hunter, 1993) . p33cdk2 appears to function predominantly during G1 and S phase (Fang and Newport, 1991; Pagano et al., 1993) . Consistent with this, p33C 2 is known to associate only with members of the cycin E, D, and A families during these phases of the cell cycle (Koff et al., 1991; Rosenblatt et al., 1992) . Association with cyclin A, for example, is accompanied by phosphorylation on a threonine at position 160 (T160), resulting in a 100 000-fold increase in the kinase activity of the complex Connell-Crowley et al., 1993) . p34cdc2, which is required for entry into M-phase, associates with cyclin A but principally with cyclin B (Pines and Hunter, 1989; Gautier et al., 1990) . Studies on the p34cdc2-cyclin B kinase (previously known as maturation-, M phase-, or mitosis-promoting factor [MPF] ) in fission yeast and vertebrate cells have provided the most complete description of the mechanisms of cdk regulation. Cyclin B accumulates in the cell during G2, associates with p34cdc2, and allows the cyclin B-dependent phosphorylation of tyrosine (Y15) and threonine (T14 and T161) residues. T14 and Y15 phosphorylation dominantly inhibits p34cdc2 kinase function, whereas T161 phosphorylation is essential for p34cdc2 kinase activity (Krek and Nigg, 1991; Norbury et al., 1991) . The protein kinase weel (and also mikl) is responsible for the inhibitory Y15 phosphorylation during interphase (Lundgren et al., 1991; Parker et al., 1992; McGowan and Russell, 1993) , whereas the phosphatase cdc25, which is activated at the end of G2, dephosphorylates Y15 and activates the p34cdc2 causing entry into M phase Millar et al., 1991) . Cyclin B degradation during anaphase is followed by the dephosphorylation of T161, kinase inactivation, and exit from M phase (Lorca et al., 1992) . In budding yeast the role of Y15 phosphorylation during G2, entry into M-phase (Amon et al., 1992; Sorger and Murray, 1992) , and also the requirement for cyclin degradation for exit from mitosis (Surana et al., 1993) is less clear.
Until recently the kinase responsible for the essential activating phosphorylation of p34cdc2 T161 remained unknown, although partial purification of an activity known as cdc2-activating kinase (CAK) from Xenopus eggs (Solomon et al., 1992) and cultured mammalian cell extracts (Desai et al., 1992) suggested that a single kinase was responsible for phosphorylation of both T161 on p34cdc2 and also the corresponding T160 on p33cdk2. Recent work in our laboratory has resulted in collaborations that have established that a kinase known as p40MO15 forms the catalytic subunit of CAK (Fesquet et al., 1993; Poon et al., 1993; Solomon et al., 1993). p40MOl5 is a 40-kDa protein serine/threonine kinase that has 43% amino acid sequence identity with p34cdc2
and is encoded by a Xenopus oocyte cDNA clone (MO15) that we isolated 4 y ago (Shuttleworth et al., 1990) . Together with our collaborators we have recently shown that in Xenopus and starfish oocytes and eggs, p40MOl5
forms the catalytic subunit of CAK and is the kinase responsible for phosphorylating cdc2 on T161 and cdk2 on T160 (Fesquet et al., 1993; Poon et al., 1993; Solomon et al., 1993) . Active p40M015 is present in high molecular weight complexes and requires phosphorylation on a threonine (T176) equivalent to T161 in p34cdc2, suggesting that it associates with other proteins and may be regulated in a similar manner to cdk's.
The ovaries of adult Xenopus laevis contain oocytes at various stages of oogenesis, which are classified according to Dumont from stage I (previtellogenic, <0.25 mm diameter) to fully differentiated stage VI (1.2 mm diameter) (Dumont, 1972) . During oogenesis, oocytes grow and accumulate stockpiles of various molecules, including proteins and mRNAs that are required for formation of a mature egg and for the events of early embryogenesis. Throughout this period of differentiation, which can last for several years, the oocytes remain arrested in diplotene of prophase meiosis I. Fully grown stage VI oocytes contain significant amounts of inactive p34cdc2-cyclin B2 complex (or "pre-MPF") where cdc2 is phosphorylated on both T161, T14, and Y15, together with a 10-fold excess of monomeric p34cdc2 (Gautier and Maller, 1991) . Progesterone stimulates activation of p34cdc2-cyclin B (or MPF) and several other kinases including c-mos and mitogen-activating protein kinase (Nebrada and Hunt, 1993) , resulting in resumption and completion of meiosis I, followed by arrest in metaphase of meiosis II as mature oocytes (or eggs) containing high levels of p34cdc2 activity (Smith, 1989) . Stage VI oocytes contain very little p33cdk2 or cyclin A protein; however, during meiotic maturation p33cdk2, cyclin B1, and cyclin A are accumulated (Kobayashi et al., 1991; Paris et al., 1991) . Fertilization of eggs triggers cyclin degradation, inactivation of p34cdc2, and completion of meiosis II, followed by entry into the rapid mitotic cell cycles of the early embryo. These rapid mitotic cycles involve periodic synthesis and destruction of cyclins that drive the activation and inactivation of p33cdk2 and p34cdc2 and execution of S and M phase (Murray and Kirschner, 1989) .
To understand how p40Mol`functions to regulate cdk activity during the varied cell cycle events of oogenesis and embryogenesis, we have investigated its expression and activity in Xenopus oocytes and embryos. We present here data that shows that p40M`l5 is a stable protein that accumulates predominantly in the nucleus during oogenesis. The p40MOl`persists at a constant level through meiotic maturation, fertilization, and .36 h into early development. Furthermore, we can detect no significant changes in MO15 kinase activity during oogenesis, meiotic maturation, or during the rapid mitotic divisions of early embryogenesis. We conclude that p40MolS is constitutively active in Xenopus oocytes and embryos and discuss the possible implications of these observations for regulation of p34cdc2 and p33Cdk2 activity in these cells.
MATERIALS AND METHODS Oocytes and Embryos
Oocytes stages II-VI were obtained from adult female Xenopus laevis frogs and maintained in modified Barth's medium (Barth-X) as de-scribed in Colman (1984) . When oocytes were to be matured by incubation in 5 ,ug/ml progesterone, the frog was primed 2 d before isolation of oocytes by injection with 100 U of follicle-stimulating hormone. Unfertilized eggs and embryos were obtained as described by Gurdon (1977) .
Immunocytochemistry
Ten-micrometer sections of unfixed stage VI oocytes mounted in OCT mounting medium (Tissue-Tek, Raymond Lamb, London, United Kingdom) were taken in a cryostat (Bright Instruments, United Kingdom) at -30°C and fixed briefly in ice-cold acetone. Staining of sections was performed (in a humidity chamber) with MO15-specific immune serum 15SSRV (Shuttleworth et al., 1990) or preimmune serum at 1/ 50 dilution together with nucleoplasmin-specific mouse ascites supernatant PA3L5 (a generous gift provided by Colin Dingwall, CRC/ Wellcome Institute, Cambridge) at 1/100 dilution for 1 h. Sections were washed extensively in phosphate-buffered saline (PBS), 1% fetal calf serum, 0.5% Tween-20 then incubated for 40 min with alkaline phosphatase-conjugated goat anti-rabbit IgG at 1/1000 dilution and fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG at 1/100 dilution. Sections were washed, stained using Vector Red substrate staining kit (Vector Laboratories, Peterborough, United Kingdom) for 15 min, and washed thoroughly again. Stained sections were mounted in PBS/glycerol mounting medium containing anti-fade compound (Citiflour, London, United Kingdom) and sealed. Slides were viewed (magnification X32) using a Leitz diaplan microscope (Rockleigh, NJ). Images were photographed using a photoautomat on Kodak Ektachrome 160T film (Rochester, NY).
Metabolic Labeling of Oocytes with 35S-methionine
Oocytes were incubated in 5 IAI per oocyte of Barth-X containing 1 mCi/mi 35S-methionine for 4 hat 23°C. After labeling some samples, where indicated in the experiment, were chased in Barth-X containing 1 mM cold methionine for 16 h.
Protein Analysis
Oocytes and embryos were homogenized in ice-cold RIPA buffer (20 mM tris(hydroxymethyl)aminomethane [Tris]-HCl pH 7.5, 100 mM NaCl, 15 mM ethylene glycol-bis(i3-aminoethyl ether)-N,N,,N1N-tetraacetic acid pH 8, 1% Nonidet P-40 containing a cocktail of protease and phosphatase inhibitors: 1 mM phenylmethylsulphonyl fluoride, 10 Mg/ml leupeptin, 10 MM pepstatin, 80 mM fB-glycerophosphate, 1 mM NaF, 1 mM Na vanadate). Homogenates were then centrifuged at 14 000 rpm for 2 min at 4°C, and the pellets were discarded.
Immunoprecipitations were performed either in ice-cold RIPA buffer for sarnples destined for kinase assays or IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% deoxycholate, 0.1% sodium dodecyl sulphate [SDS] containing the same cocktail of protease and phosphatase inhibitors as listed above) for samples containing 35S-methionine-labeled protein. Immune complexes were formed using MO15-specific immune serum 15SSRV (Shuttleworth et al., 1990) or preimmune serum (at 1/500 dilution for l h at 4°C), immobilized on 10 Ml protein A sepharose (1 hour at 4°C on a turning wheel), and washed four times in 100 vol of icecold RIPA before kinase assays, or for samples containing 35S-methionine labeled protein, four times in ice-cold IP buffer followed by boiling in 20 Ml of 2X sample buffer and analysis by 10% SDS-polyacrylamide gel electrophoresis (PAGE).
Immunoblotting
Homogenates of oocytes and embryos were prepared (as described above) and spun at 14 000 rpm in a microcentrifuge at 4°C for 2 min. for 30 min. The membrane was then washed with four changes of TBST for 30 min with gentle agitation and developed using an enhanced chemiluminesence (ECL) kit (Amersham). Membranes were exposed to autoradiographic film (Hyper-MP, Amersham), and the resulting signal was quantitated using scanning densitometry (Ultraviolet Products, Enhanced Analysis System). In each case a dilution series of recombinant GST15 protein was included as an internal standard. All measurements used were within the linear region of the ECL detection method.
Isolation of Total RNA from Oocytes, Unfertilized Eggs, and Embryos
Total cellular RNA was extracted from oocytes and embryos using a Guanidium/hot phenol protocol. Groups of 10 oocytes or embryos were homogenized in 200 M1I 4 M guanidium thiocyanate, 42 mM sodium citrate, 0.83% lauryl sarcosine, 0.2 mM ,B-mercaptoethanol and incubated at 60°C for 15 min. Two hundred microliters of 0.1M CH3COONa pH 5.2, 10 mM Tris-HCl pH 7.5, 1 mM EDTA was added, followed by 400 Ml of phenol/chloroform. The mixture was vortexed briefly and incubated at 60°C for 10 min with regular vortexing. The aqueous layer was separated by microcentrifugation at 14 000 rpm for 15 min and reextracted with 400 ,l of phenol/chloroform followed by a chloroform extraction. RNA was collected by ethanol precipitation.
Ribonuclease Protection Assay pMO15 plasmid DNA (Shuttleworth et al., 1990) was digested with Dra II deleting 787 base pairs (bp) from the 3' end of the MO15 cDNA, and the parent molecule was religated. This construct was linearized with Sst I and used to transcribe a 689 nucleotide (nt) 32P-labeled antisense cRNA probe with T7 RNA polymerase (Pharmacia, Piscataway, NJ) as described previously (Horrell et al., 1987) . p6BC (partial Xenopus ornithine decarboxylase cloned into pBluescript KS-vector, a generous gift of Dr. H. Osborne, Rennes) was linearized with Xho I and used to generate a 454 nt 32P-labeled antisense ODC cRNA probe using T7 RNA polymerase. In vitro transcriptions and ribonuclease protection assays were performed as described by Horrell et al. (1987) . For each sample, 5 X 104 cpm of gel-purified riboprobe was ethanol precipitated with (10 Mg) oocyte or embryo RNA at -20°C for 16 h. After RNase digestion products were analyzed by electrophoresis in a 4% polyacrylamide/ 8M urea gel followed by autoradiography.
Expression and Purification of Recombinant Proteins from Bacteria
Construction of GST-cdk2 and GST-cdk2T160A (kind gifts of Dr. T. Hunt, Imperial Cancer Research Laboratories, South Mimms, United Kingdom) were described by Tsai et al. (1991) and Poon et al. (1993) .
The fusion proteins were expressed in Escherichia coli strain BL21(DE3) and purified as described by Poon et al. (1993) .
CAK Assay by Direct Phosphorylation of GST-cdk2
Samples to be assayed for CAK activity were immunoprecipitated using 15SSRV MO15-specific immune serum or preimmune serum (Shuttleworth et al., 1990) as described above. Kinase activity was measured by incubating the immune complexes in a volume of 25 ,l containing the following: 1 ,ug of purified bacterially expressed GSTcdk2 or GST-cdk2Tl6OA, 15 mM Mg(OAc)2, 30 ,tM ATP and 3 , uCi [y_32p] ATP at 23-C for 45 min with mixing. The reaction mix was separated by microcentrifugation at 14 000 rpm for 2 min at 4°C, and 25 ul of 2X SDS-PAGE sample buffer was added to the supematant. Samples were boiled for 5 minutes and electrophoresed on 10% SDS-PAGE. Dried gels were analyzed by phosphorimage analysis (Molecular Dynamics, Sunnyvale, CA) to quantitate the relative phosphorylation of GST-cdk2 protein and also exposed to X-ray film.
RESULTS

Expression of M015 Protein During Oogenesis and Early Development
From previous data we knew that adenylated M015 transcripts are accumulated during early oogenesis (Shuttleworth et al., 1990) . To establish whether these transcripts are being translated, oocytes at various stages of oogenesis were labeled for 4 h in 35S-methionine, homogenized, and immunoprecipitated with M015-specific 15SSRV antibody (Shuttleworth et al., 1990) . Figure 1A Figure 3A were assayed for transcripts of ornithine decarboxylase, a housekeeping gene, and produced a similar signal from each stage of embryogenesis ( Figure 3B ), indicating that the loss of signal from M015 transcripts in Figure 3A is These results were unexpected in view of the prediction that very little p40M15 would be translated to maintain p40T015 levels during the first 36 h of development (see above), and they suggested that p40MOl5 is an extremely stable maternal protein with a low rate of turnover. To confirm the previously reported loss in MO15 transcripts during early embryogenesis, we used the more sensitive technique of the RNase protection assay. Figure 3A shows that whereas M015 cRNA gave rise to a single protected fragment of the predicted size (lane 1), RNA extracted from stage VI oocytes and embryos gave rise to three protected fragments: one at 579 nt, the size predicted for M015, and shorter fragments at 504 nt and 488 nt. The shorter fragments may be derived from allelic versions of M015 (Xenopus is pseudotetraploid) or from incompletely processed species of mRNA that are known to be present in maternal RNA. Figure 3A shows Figure 5B ). By comparison, staining with preimmune serum gave no signal within the GV ( Figure 5C ), whereas nucleoplasmin was still clearly detected ( Figure  5D ). Background fluorescence in the cytoplasm was similar using both immune and preimmune serum (Figure 5A , and C). p40M`l5 therefore has a nuclear and not perinuclear localization. Similarly, using indirect immunofluorescence, we found that the p4OMOl5 present in stage 9 embryos is localized to nuclei, coincident with the distribution of nucleoplasmin (unpublished observations p4OM015 from oocytes and embryos directly for their ability to phosphorylate purified bacterially expressed GST-cdk2 fusion protein, using mutated nonphosphorylatable GST-cdk2/Tl6OA protein as a control for specificity. Figure 6A shows that p4OMolS immune complexes containing equivalent amounts of p4OM15 (see Figure 1) Because p4OM°15 occurs in both the GV (84%) and cytoplasm (16%) of stage VI oocytes (see Figure 4) , we next asked whether these two populations of protein were equally active. Oocytes were manually dissected, and immune complexes were prepared from GVs and cytoplasm. Figure 6B shows that 77% of the recovered p4OMOi5 activity was associated with the GV (lane 1) and 23% with the cytoplasm (lane 2), approximating the distribution of p40 015 protein detected by immunoblotting (Figure 4) . Again, no significant phosphorylation of GSTcdk2/T160A was detected using immune complexes prepared from total stage VI oocytes (lane 4), whereas immune complexes prepared from stage VI oocytes using preimmune serum gave no significant phosphorylation of GST-cdk2 (lane 5). p4oMOl5 therefore appears to be equally active in both the nucleus and the cytoplasm of stage VI oocytes.
Progesterone stimulation and resumption of meiosis in fully grown oocytes is accompanied by profound changes in p34cdc2-cyclin B activity. Increases in the histone Hi kinase activity of the complex can be detected within 2 h of stimulation. In contrast, we detected no change in the kinase activity of p4OMOl5 after stimulation with progesterone ( Figure 6C ). p4OMOlS was equally active in stage VI oocytes before addition of progesterone (lane 1), and 0 (lane 2), 2 (lane 3), and 17 h (lane 4) after addition of progesterone, by which time they had matured and arrested in metaphase of meiosis II.
A similar picture emerges for p4OMOl5 kinase activity during early embryogenesis. p4OMOl5 immune complexes (containing equivalent amounts of p4OMOl5) prepared from an equal number of cleaving embryos, sampled before mitosis 5 and at -10-min intervals until mitosis 6 was completed, were assayed for both cdk2 T160 and histone Hi kinase activity. As expected, the levels of histone Hi kinase activity dropped during interphase and increased during M phase (unpublished observations). In contrast, Figure 7A shows no change in the activity of p4OMOl5 during M phase, mitosis 5 1-3) (lane 2), interphase (lanes 3-6) to M phase, mitosis 6 (lane 7). The activity of p40MOl5 is therefore not regulated during the mitotic cell cycle of early cleaving embryos. Finally Figure 7B shows the CAK activity associated with p40MolS during early embryogenesis. Immune complexes prepared from an equal number of mature stage VI oocytes (lane 1) and stage 2-30 embryos (lanes 2-8) contained equivalent levels of cdk2 T160 activity. The variation between samples (-2-to 3-fold) seen in this experiment was not reproducible and can be attributed to experimental error (losses during the multiple step procedure transcripts are present early in oogenesis (Shuttleworth et al., 1990) . The amounts of p40MOlS accumulated in stage VI oocytes are maintained at a remarkably constant level through meiotic maturation, fertilization, and early embryogenesis, despite the fact that M015 transcripts become deadenylated during meiotic maturation (Shuttleworth et al., 1990 By comparison, the stability of p34cdc in proliferating mouse 3T3 cells has been reported to vary from a halflife of 18 h during early Gl to only 7.5 h during G1/ S-phase (Welch and Wang, 1992) . It remains possible that a protein closely related to p4OMOl5 is expressed by embryos after the drop in MO15 transcript levels in stage 8 embryos, the point at which zygotic transcription begins. If this were the case, the maternal pools of p40Mol1 could be replaced by newly synthesized embryonic protein cross-reactive to the anti-MO15 immune serum used. These hypothetical MO15-related transcripts would not necessarily be detected either by our previous Northern blot analysis (using high stringency hybridisation with a 500-bp 5'-end probe) or bSy RNase protection analysis. The p40 015 protein present during oogenesis, meiotic maturation, and early embryogenesis appears to be constitutively active. Usinga direct assay for the cdk2 T160 kinase activity in p40015 immunoprecipitates, we have found no significant changes in the relative specific activity of p40M'l' present in the nucleus or cytoplasm of prophase-arrested oocytes, maturing oocytes, or rapidly cleaving early embryos. It remains possible that although GST-cdk2 can be phosphorylated by immune complexes of p40MolS in vitro, cyclin association with cdk2 subunits may modulate T160 phosphorylation during cell cycle progression in vivo by altering its affinity or accessibility as a substrate for p40MOl5. Our in vitro kinase assay, using GST-cdk2 alone as a substrate, may fail to detect changes in the activity of p40Ml15.
However, this seems less likely in view of previous reports that the CAK activity associated with extracts prepared from interphase and M-phase embryos and prophase-arrested oocytes remains constant when assayed using cdc2-cyclin B as a substrate (Solomon et al., 1992) . Like somatic cells, which accumulate p34cdc2-cyclin B complexes during G2, Xenopus oocytes arrested in prophase (at the G2/M boundary) contain a significant pool of cyclin B2 that is complexed with T14-, Y15-, and T161-phosphorylated p34cdc2 (Gautier and Maller, 1991) . Activation of this p34cdc2-cyclin B2 pool in response to progesterone requires no new synthesis of cyclin Bi, B2, or A , and dephosphorylation of p34cdc2 T14 and Y15 by cdc25 phosphatase leads rapidly to GV breakdown and completion of meiosis I . p34cdc2-cyclin B purified from prophase-arrested starfish oocytes can similarly be activated in vitro by recombinant cdc25, confirming that T161 is already phosphorylated (Strausfeld et al., 1991) . The existence of an active p34cdc2 T161 kinase in prophase-arrested oocytes is therefore entirely consistent with this model. Precise details of the events that lead to inactivation and subsequent reactivation of p34cdc2, between meiosis I and meiosis II, have yet to be described. There are obvious differences in the mechanism regulating exit from metaphase during meiosis I compared to mitosis, including the fact that not all cyclins are destroyed after meiosis I (Kobayashi et al., 1991) . Therefore it is possible that other processes Expression and Activity of p4OMoI5 unique to meiosis may regulate cdc2 kinase activity.
Until the fate of the p34cdc2 T161 phosphate is known, we can only speculate that MO15 may be required again after meiosis I to reactivate p34cdc2 complexes and enter meiosis II. However, the absolute requirement to maintain the kinase activity of the p34cdc -cyclin complexes during metaphase meiosis II arrest in mature oocytes/ eggs would dictate that p40M015 remains active during this period. Similarly, the requirement to activate p33c2M and p34cdc2 kinase complexes that drive S phase and M phase in the early embryo would again leave very few occasions when the activity of p4OM l5 is not necessary, assuming that p34cdc2 T161 and p33cdk2 T160 are dephosphorylated during each cycle. A human homologue of p4OMO has recently been identified and similarly shown to be constitutively active throughout the cell cycle in proliferating human somatic cells (Tassan et al., 1994) .
The constitutive activity of p40mUl5 is in marked contrast to the cell-cycle regulation of weel kinase and cdc25 phosphatase activities, even in the rapid mitotic cycles of the frog early embryo that lack many aspects of control present in somatic cell cycles (Kumagai and Dunphy, 1992; Tang et al., 1993) . Phosphorylation of p34cC2 Y15, its effect being dominant over T161 phosphorylation, is clearly the preferred mechanism for tightly regulating cdk activity during the transition from G2 into M-phase. The equivalent "fine tuning" of cdk activity at other points in the cycle could be exerted by titration of inhibitory proteins that override T161/T160 phosphorylation and remove the need to tightly regulate CAK activity (Nasmyth and Hunt, 1993) .
By direct immunoblotting of dissected oocytes, we found that 84% of p40Mol is localized to the GV of stage VI oocytes. The remote possibility that the small (16%) cytoplasmic population of p40MO15 iS caused by leakage from the GV during dissection is unlikely but cannot be excluded. Unfortunately, no suitable control exists to confirm the absence of contamination of cytoplasm by soluble GV proteins. Even proteins such as nucleoplasmin, which are exclusively nuclear in somatic cells, are known to be present (-10%) in the cytoplasm of Xenopus oocytes. Leakage from the GV is more likely to present a problem after dissection, although this does not appear to compromise the data presented in Figure  4 where virtually all of the p40MOl detected in intact oocytes can be accounted for. Our immunofluorescence studies indicated a uniform distribution throughout the GV. The predicted amino acid sequence near the Cterminus of Xenopus p4oMol5, and also in human and mouse p40MOl5 homologues (Erschler et al., 1993; Tassan et al., 1994) , contains a putative bipartite nuclear localization signal (Robbins et al., 1991) that may explain this distribution; however, we have not formally tested this possibility. The fact that we find p40M`l in the nuclei of embryos after the midblastula transition (Brown, unpublished data), together with the observation that p4oM0l5 is localized predominantly to the nucleus during interphase in human somatic cells (Tassan et al., 1994) , suggests that it functions as a nuclear kinase in all cell types.
Interpretation of the nuclear localization of p4OMOlS is problematical and highlights possible gaps in our knowledge of the precise details of events occurring during release from prophase arrest in oocytes and during the G2/M transition in somatic cells. No problem exists for T160 phosphorylation of p33cdk2 complexed with either cyclin D, E, or A, all of which are nuclear proteins throughout the cell cycle (Pines and Hunter, 1991; Sherr, 1993) . Because somatic cells spend the majority of their time passing through G1, S, and G2 phases of the cell cycle, the nuclear localization of active p40MOl`throughout interphase should not be surprising. However, considering p34cdc2-cyclin B, the only other confirmed substrate for p40M'l5 in Xenopus, this discovery is intriguing. Stage VI Xenopus oocytes contain significant amounts of p34cdc2 and cyclin B2 but very little p33C 2, cyclin A, or cycin Bi (Gautier and Maller, 1991; Kobayashi et al., 1991; Paris et al., 1991) . All of the cyclin B2 exists in complex with p34cdc2 exclusively in the cytoplasm (Gautier and Maller, 1991) , consistent with the observation that cyclin B is a cytoplasmic protein until the G2/M transition in human somatic cells (Pines and Hunter, 1991) . The presence of a cytoplasmic population of active p4OM"1 (-20% of the total) in oocytes could ensure that the p34cdc2-cyclin B2 is T161 phosphorylated. Data on the localization of p34cdc2 in somatic cells is confficting, with reports of its distribution only in the nucleus (Riabowol et al., 1989) , only in the cytoplasm (Akhurst et al., 1989) , in both (Bailly et al., 1989) , or with populations able to relocate during the cell cycle (Ookata et al., 1992) . The nuclear localization of both p4OMOlS and cdc25 (Girard et al., 1992 ) is difficult to reconcile with a simple model for p34Cdc2_cyclin B activation, because cyclin B bound to p34cdc2 remains cytoplasmic during interphase (Pines and Hunter, 1991) and only moves to the nucleus at the G2/M transition, concomitant with activation of p34cdc2. The presence of relatively small cytoplasmic populations of p4OMOl5 and cdc25 could allow the observed behavior of p34cdc2_cy_ clin B, triggering the positive feedback loop that has been postulated to initiate rapid activation of p34cdc2. Alternatively, small amounts of p34cdc2-cyclin B may enter the nucleus with the same effect.
We detect a small but potentially significant population of p34cdc2 associated with dissected stage VI oocyte GVs (Shuttleworth, unpublished data) . This GV population, representing 10% of the total p34cdc2 pool, is indistinguishable from cytoplasmic p34cdc2 by its electrophoretic mobility, suggesting that Y15 and T161 phosphorylated forms are present in the GV and are associated with cyclin (Shuttleworth, unpublished data) .
If this is the case, the identity of the cyclin involved and the function of this GV population of p34cdc2 re-mains open to question. Only cyclin A and the newly identified cyclin B3 localize to the nucleus in interphase cells (Pines and Hunter, 1991; Gallant and Nigg, 1994) and are potential partners for p34cdc2. However, only insignificant (<1 pg) amounts of cyclin A are present in prophase-arrested oocytes (Kobayashi et al., 1991) , and the expression of cyclin B3 in these cells has yet to be reported. Provocativelt, preliminary data on the kinetics of activation of p34cdc in progesterone-stimulated Xenopus oocytes suggests that Hi kinase activation in the GV preceeds activation in the cytoplasm, the proposed location of all p34cdc2-cyclin B2 or pre-MPF (Shuttle--worth, unpublished data). Immediately before GV breakdown, the GV-associated histone Hi kinase activity represents 10% of the total activity present in the oocyte. The precise function and behavior of p34cdc2_ cyclin A, particularly during G2 and M-phases, remains unclear. There are clear differences in aspects of its function and behaviour compared to p34cdc2-cyclin B (Lehner and O'Farrell, 1990; Minshull et al., 1990) . Notably, p34cdc2-cyclin A, unlike p34cdc2-cyclin B, is a poor substrate for weel kinase (Clarke et al., 1992) . (Poon et al., 1993) . This, together with the observation that recombinant GST-MO15 protein purified from bacteria requires incubation with cell extract to acquire CAK activity (Poon et al., 1993) , has led us to propose that p40M`lS activity is regulated by association with regulatory subunit(s) and/or phosphorylation of specific residues such as the T176, which is at a position corresponding to p34cdc2 T161. Homogenization and immunoprecipitation may alter the activity of p40MOl5 complexes, if for example regulatory components are lost or gained during the process. Also, in the presence of phosphatase inhibitors we have observed forms of p40MOl5 with faster mobilities on SDS-PAGE (Brown, unpublished data). We believe these represent extremely labile phosphorylated forms of the kinase. Although we have detected no differences in the activity of p40MOl`that can be associated with this phosphorylated form, it is possible that phosphorylation of specific residues, such as a putative p34cdc2 phosphorylation site at serine 170, may regulate localization, complex formation, or substrate recognition in vivo. We are currently investigating the identity of a 35-kDa protein that specifically coprecipitates with p40MOl5 from Xenopus oocytes and could be a putative regulatory subunit of CAK. Similarly, two proteins with molecular weights of 32 and 34 kDa have been found to specifically coprecipitate with the human homologue of p40M°15 from Hela cells (Tassan et al., 1994) , whereas a 37-kDa protein has been found associated with purified human CAK (Fisher and Morgan, 1994) . Studies on the expression, localization, and function of such regulatory proteins, and their association with p40Mol`during oogenesis and embryogenesis and during the somatic cell cycle, will be required to understand in more detail how p40M15 function is regulated throughout the meiotic and mitotic cell cycles.
